A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT04988308 · TERMINATED
Trial details
- NCT number
- NCT04988308
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2022-10-14
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.